Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 10(9)/L to <100 × 10(9)/L) at baseline: the final analysis of EXPAND
鲁索替尼治疗基线血小板计数低（50 × 10⁹/L 至 <100 × 10⁹/L）的骨髓纤维化患者的疗效和安全性：EXPAND 研究的最终分析
期刊:Therapeutic Advances in Hematology
影响因子:3.1
doi:10.1177/20406207221118429
Guglielmelli, Paola; Kiladjian, Jean-Jacques; Vannucchi, Alessandro M; Duan, Minghui; Meng, Haitao; Pan, Ling; He, Guangsheng; Verstovsek, Srdan; Boyer, Françoise; Barraco, Fiorenza; Niederwieser, Dietger; Pungolino, Ester; Liberati, Anna Marina; Harrison, Claire; Roussou, Pantelia; Wroclawska, Monika; Karumanchi, Divyadeep; Sinclair, Karen; Te Boekhorst, Peter A W; Gisslinger, Heinz
